TRACY FERSHEE: Open Payments
NPI 1063977643 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,932 in 122 payments from 21 companies in 2025. Trend: 2023 $1,826 · 2024 $2,120 · 2025 $2,932
Food & beverage: $2,819Education: $113
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $625 |
| GlaxoSmithKline, LLC. | 32 | $427 |
| Regeneron Healthcare Solutions, Inc. | 14 | $361 |
| Baxter Healthcare | 8 | $208 |
| GENZYME CORPORATION | 7 | $175 |
| Pulmonx Corporation | 8 | $168 |
| Amgen Inc. | 8 | $145 |
| Merck Sharp & Dohme LLC | 5 | $112 |
| INTUITIVE SURGICAL, INC. | 1 | $99 |
| Viatris Specialty LLC | 4 | $88 |
Products named: DUPIXENT, FASENRA, TEZSPIRE, NUCALA, Hillrom - Vest System Model 105 Home Care, TRELEGY ELLIPTA, CHARTIS CATHETER, ZERBAXA.
Industry payments across AZ — which companies pay providers there.
